Evidence map›Paper›PMID 33202739›Full record

ArticlePharmaceuticals (Basel, Switzerland)2020

3-Pentylcatechol, a Non-Allergenic Urushiol Derivative, Displays Anti-

Hang Yeon Jeong, Tae Ho Lee, Ju Gyeong Kim, Sueun Lee, Changjong Moon, Xuan Trong Truong, Tae-Il Jeon, Jae-Hak Moon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Bamboo Salt and Triple Therapy Synergistically InhibitInternational journal of molecular sciences · 2022
    Article
  2. Special Issue "Novel Antibacterial Agents".Pharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hang Yeon JeongDepartment of Food Science and Technology, Chonnam National University, 77 Yongbongro, Gwangju 61186, Korea.ORCID 0000-0001-5429-9181
Tae Ho LeeDepartment of Food Science and Technology, Chonnam National University, 77 Yongbongro, Gwangju 61186, Korea.ORCID 0000-0001-7764-3264
Ju Gyeong KimDepartment of Food Science and Technology, Chonnam National University, 77 Yongbongro, Gwangju 61186, Korea.ORCID 0000-0002-3666-1578
Sueun LeeDepartment of Veterinary Anatomy, College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju 61186, Korea.
Changjong MoonDepartment of Veterinary Anatomy, College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju 61186, Korea.ORCID 0000-0003-2451-0374
Xuan Trong TruongDepartment of Animal Science, Chonnam National University, Gwangju 61186, Korea.
Tae-Il JeonDepartment of Animal Science, Chonnam National University, Gwangju 61186, Korea.ORCID 0000-0003-0655-8614
Jae-Hak MoonDepartment of Food Science and Technology, Chonnam National University, 77 Yongbongro, Gwangju 61186, Korea.
Chonnam National University · KR

Funding

National Research Foundation of Korea NRF-2020R1A2C2013711
6 · The paper itself

Abstract

We previously reported that 3-pentylcatechol (PC), a synthetic non-allergenic urushiol derivative, inhibited the growth of

Indexed as

3-pentadecylcatechol3-pentylcatecholantimicrobialHelicobacter pyloritriple therapyurushiol

Identifiers

PMID33202739
PMCPMC7697961
OpenAlexW3105371014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.